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Background: To describe the clinical epidemiology, environmental surveillance and infection control interventions
undertaken in a six-year persistence of bla-IMP-4 metallo-beta-lactamase (MBL) producing Enterobacteriaceae within
a separately confined hospital burns unit in a tertiary hospital in Sydney, Australia.
Methods: MBL positive clinical and environmental isolates were collected from the Burns Unit, from the first detection of
isolates in September 2006 to August 2012. Unit-acquired clinical isolates were included, and patient outcomes analyzed
amongst those who acquired clinically significant infections. Environmental isolates were analyzed with regard to
relationship to clinical isolates, bacterial species, and persistence despite cleaning efforts.
Results: Thirty clinical isolates detected from 23 patients were identified. Clinically significant infection
developed in 7 (30%) patients – 2 bacteremias, 2 central venous catheter tip infections without bacteremia, and
3 wound infections. All patients survived at 30 days. Seventy-one environmental isolates were confirmed to be
MBL-positive, with 85% sourced from shower facilities or equipment. MBL organisms persisted at these sites despite
both usual hospital cleaning, and following targeted environmental disinfection interventions.
Conclusions: Clear association exists between environmental Burns Unit contamination by MBLs and subsequent
patient colonization. Clinical infection occurred in a small proportion of patients colonized by MBLs, and with generally
favorable outcomes. Its persistence in the Burns Unit environment, despite concerted infection control measures, pose
concern for ongoing clinical transmission.
Keywords: Carbapenem-resistant Enterobacteriaceae, bla-IMP-4 metallo-beta-lactamase enzyme, Hospital-acquired
infection, Infection control, Environmental surveillanceBackground
Carbapenem-resistant Enterobacteriaceae (CRE) have
emerged as a global issue, particularly in the nosocomial
setting [1]. Bla-IMP-4 type Ambler Class B metallo-beta-
lactamases (MBL) are the predominant type detected in
Australia [2,3], after being first identified in 2002 [4].* Correspondence: thomas.gottlieb@sswahs.nsw.gov.au
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stated.Apart from a well-described clinical outbreak in 2004
[5,6], and a recent description of an outbreak in an inten-
sive care unit potentially attributed to hand-washing sinks
[7], there have been few publications describing MBL
outbreaks in the Australian clinical setting. Worldwide
there have been other published outbreak examples,
due to multi-drug resistant Gram-negative bacteria in-
cluding Pseudomonas aeruginosa, extended-spectrum
beta-lactamases (ESBLs) and carbapenemases [8-10].
A recent study by Betteridge et al. [11] performed on
specimens from the Concord Repatriation General HospitalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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MBL isolates and confirmed the strains to be genetically
identical, confirming the hospital environment as an im-
portant reservoir. This study describes the clinical out-
break, the environmental surveillance performed, and the
infection control interventions undertaken.
Methods
Setting
CRGH is a 550-bed tertiary hospital in Sydney Australia,
and contains the statewide referral unit for severe burns
injury, which receives 200 to 300 admissions per year.
The Burns Unit (BU) is an enclosed unit containing 8
single rooms and 3 two-bedded rooms. The single rooms
are attached to a separate anteroom for hand-washing
and donning standard contact precautions (gowns and
gloves), which are mandatory regardless of multi-resistant
organism (MRO) colonization status. The two-bedded
rooms are infrequently used. Five shower facilities are
shared amongst the patients. A dedicated burns operating
theatre is located adjacent to the Unit. Patients with severe
burns are frequently admitted into the intensive care unit
(ICU) prior to transfer to BU; inter-hospital transfers rep-
resent approximately 50% of presentations.
Routine screening of patients for MBL organisms
was not performed during the study period; patient
specimens were collected based on clinical need. En-
vironmental screening for Gram negative MROs within
patient rooms occurred following patient discharge
from the BU and terminal room disinfection. Other
specimens were collected from sites within shared
shower rooms and sluices. Regular itemized point-
prevalence environmental screening was adopted within
the BU from October 2011.
In September 2006, a patient known to be colonized
with bla-IMP-4 MBL Enterobacter cloacae was transferred
from another hospital to the BU. The IMP-4 positive sta-
tus was confirmed on wound swabs performed on arrival,
and became the index MBL-positive case for the hospital.
Since this time, there has been ongoing MBL acquisition
among patients admitted into the BU. We describe the
clinical epidemiology of this outbreak since this time,
until the end of our study period in August 2012.
Study inclusion
All MBL isolates detected in the hospital within the study
period were identified. “Burns-related” isolates were in-
cluded, and defined as isolates from patients who had
dwelled in the BU prior to, or at the time of collection
during that same admission. Of these, only original iso-
lates were included. An original isolate was defined as 1)
the first MBL isolate detected in that patient, 2) subse-
quent MBL isolate from a patient, but detected in a new
site, e.g. blood cultures from a patient known to be MBLfrom the skin; this was included to detect possible clin-
ical infection after colonization, and/or 3) subsequent
MBL isolates from a patient, but detected in new
genus, e.g. MBL-producing Klebsiella pneumoniae in a
patient previously colonized with MBL-producing En-
terobacter cloacae. From the included isolates, patient
records were identified to determine clinical signifi-
cance, treatment and outcomes.
Exclusion criteria included 1) patients who were found
to harbor an MBL isolate on arrival to the BU, suggest-
ing prior acquisition from another source; and 2) subse-
quent isolates from the same site, such as repeat skin
swabs from a patient known to have MBL-producing organ-
isms colonized on the skin, and 3) carbapenem-resistant
organisms such as Acinetobacter, Stenotrophomonas and
Pseudomonas spp., in which MBL enzyme presence was
excluded on laboratory testing.
Environmental isolates obtained from the BU during
this study period retrospectively analysed, and included
if laboratory testing had confirmed the presence of MBL
enzyme.
Laboratory methods
Clinical specimens, including wound cultures, underwent
routine culture using Horse Blood and MacConkey agars.
Highly selective differential and chromogenic media were
not used for clinical specimens. Organism identification
and susceptibility testing was performed using an auto-
mated commercial system (Vitek 2, bioMerieux Australia)
with CLSI (Clinical and Laboratory Standards Institute,
USA) breakpoints. To increase the sensitivity of detecting
isolates with low levels of carbapenemase production, all
clinical isolates were additionally screened with agar dilu-
tion methods with 0.5-1.0 mg/mL meropenem agar plate.
Bacterial isolates which were resistant to meropenem on
commercial testing or which grew on the agar dilution
plate, and selected isolates that demonstrated cephalo-
sporin resistance (e.g. ESBLs), were submitted for further
testing with a Modified Hodge test and subsequent con-
firmatory testing utilizing an in-house developed multi-
plex molecular (PCR) testing for the presence of bla-IMP
or bla-VIM [12].
Environmental samples were collected using swabs to
sinks and drains. Engineering staff assisted with expos-
ure to deep and enclosed sinks. Swabs were incubated
directly into 10 mL of Brain Heart Infusion at the site of
collection. Incubated broth was incubated at 37°C over-
night and then plated onto chromogenic ESBL agars
(Oxoid Brilliance Chrome ESBL) and incubated aerobic-
ally at 37°C for a further 24 hours [13]. Enterobacteria-
ceae isolated from this selective media underwent
identification and susceptibility testing as well as mero-
penem agar dilution plate screening as described for
clinical specimens above.
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Laboratory data were collected from electronic data-
bases. Clinical information was retrieved from medical
records. BU data were obtained from the NSW Agency
for Clinical Innovation Statewide Burns Injury Service.
Statistical analysis
Bivariate and multivariate analyses were performed for
age, total body surface area (TBSA) and length of stay,
compared to likelihood of acquiring MBL organisms,
using Stata 12 (StataCorp, Texas, USA).
Results
Clinical outbreak
The CRGH Microbiology laboratory identified 92 MBL-
producing isolates over the six-year period from 63 pa-
tients. All were bla-IMP-4 positive, except for one
non-BU related VIM-1 isolate. Of these, 51 (55%) iso-
lates from 26 patients had some temporal relation-
ship to the BU. Thirty isolates (33%) from 23 patients
met the case definition (Figure 1), representing 1.5%
(23/1497) of BU patient admissions over this time.
All patients were admitted for burns management ex-
cept for one, who had a diagnosis of necrotizing fasciitis.
Eighteen (78%) of patients were male. Older age, larger
total burns surface area (TBSA) and greater length of
stay (LOS) were all significantly associated with MBL ac-
quisition on both bivariate and multivariate analysesExc
51 BU-related isolates
from 26 patients
30 isolates from 23 
patients included in 
1911 isolates associated 
with infection in 7 
patients
92 MBL isolates from 
63 patients
Exc
44 BU-related isolates 
from 23 patients
Exc
Figure 1 Flowchart of study selection criteria.(p < 0.001), as summarized in Table 1. Median num-
ber of days in BU to acquisition of MBL organism was
25 days (range 7–87). Fourteen (61%) patients had an
ICU admission prior to transfer into the BU, with a
median ICU stay of 6 days. Eighteen (75%) patients
were transferred from another hospital. Twenty-one
(92%) patients had surgery during that admission,
most commonly for debridement with or without split
skin grafting.
Fifteen (65%) patients had no known immunocompro-
mise prior to admission. Three patients had a history of
alcohol abuse, two had diabetes mellitus. One patient
had polymyalgia rheumatica, one with lung cancer in re-
mission and a previous cerebrovascular accident, and
one patient had chronic obstructive pulmonary disease
and peripheral vascular disease.
Sixteen (70%) patients had prior broad-spectrum anti-
biotics, defined as either third or fourth generation
cephalosporins, and/or broad-spectrum penicillins such
as ticarcillin-clavulanate or pipercillin-tazobactam, with
a median duration of 7 days (range 1–80 days). Four of
these patients also received carbapenems. Two patients
received no antibiotics prior to MBL acquisition.
The majority of isolates (68%, n = 21) represented
asymptomatic colonization. Enterobacter cloacae was the
most commonly detected organism, seen in 61% (n = 19)
of isolates in 16 patients. Other species identified were
Klebsiella pneumoniae (8), Enterobacter aerogenes (2),luded




41 isolates not related 
to BU from 37 patients
14 “non-original” 
isolates (duplicate sites 
and organisms)
7 isolates from 3
patients detected on
arrival to BU  









Age (years) 62 38 <0.001 1.04 <0.001
TBSA (%) 20 4 <0.001 1.03 <0.001
LOS (days) 50 6 <0.001 1.02 <0.001
LOS v TBSA correlation coefficient
(r) =0.741
<0.001
LOS v age correlation coefficient
(r) =0.260
<0.001
TBSA v age correlation coefficient
(r) =0.009
0.622
TBSA Total Burns Surface Area (as percentage of total body surface area); LOS
length of stay.
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isolation were superficial wound swabs from the burns
site (71%, n = 22), others included central venous cath-
eter tips (4), peripheral blood (2), urine (2) and respira-
tory (1) cultures.
Table 2 summarizes the characteristics, treatment and
outcomes of the 7 (30%) patients with clinical infections
attributable to MBL organisms. Amikacin was given in
all 6 patients who remained in the hospital, 3 of those in
combination with ciprofloxacin.
Of the known outcomes, 5 patients survived and were
discharged. The single patient who died had MBL E. clo-
acae identified from CVC tip cultures. She was treated
with amikacin for 5 days, subsequent blood cultures
were positive for methicillin-resistant Staphylococcus
aureus (MRSA) but no Gram-negative organisms. She
died one month after treatment for MBL infection from
respiratory failure, in the context of inhalational injury
and underlying chronic obstructive pulmonary disease.
Her cause of death was not deemed attributable to MBLTable 2 Characteristics and outcomes of 7 patients with clinic
Patient No. Age and Sex Co-morbidities Isolate site (n = 11) Organ
1 62 M Nil CVC tip Klebsiel
2 61 M Alcohol abuse CVC tip Enterob
Blood Sputum
3 36 M Alcohol abuse Wound Enterob
4 82 F COPD, PVD CVC tip Enterob
5 62 M Nil Wound Enterob
Wound Klebsiel
6 86 F Nil Wound Enterob
7 92 M Nil known Blood Klebsiel
Urine
* = died at 34 days after MBL infection, from respiratory failure related to inhalationinfection. Patient 7 had positive blood cultures de-
tected on the day he was transferred overseas for further
care; it is documented that the result of an MBL-
producing Klebsiella pneumoniae was communicated to
the overseas hospital, however his treatment and outcome
are unknown.
Environmental screening
Environmental screening for MROs conducted in the
BU has historically been done on an intermittent basis,
across a range of randomly selected environmental sites
within the BU. Sampling was usually performed from
drainage areas and shower heads in common shower
areas, and in rooms of patients known to harbor MROs
following cleaning with a local disinfectant and a phen-
olic compound. In September 2011, a point-prevalence
study was performed within the unit after a cluster of
three clinical cases was detected over a short period of
time. This additional sampling accounted for a signifi-
cantly larger amount of overall swabs taken, and thus of
positive MBL isolates (see Figure 2). In response to this
finding, monthly routine screening was instituted. De-
fined sampling of environmental surfaces included pa-
tient rooms, shared patient equipment such as hoist
chairs, bathroom facilities and plumbing, including shower
floor drains and en-suite bathroom sink drains. Staff areas
were also sampled. This was downgraded to bi-monthly
screening from January 2012, and has continued until the
time of writing.
Table 3 summarizes the confirmed MBL isolates de-
tected from environmental screening of the BU over this
period. Since 2008 when molecular confirmation for
MBL with IMP-4 PCR testing was instituted on environ-
mental isolates, 4495 isolates have been collected, with
71 MBL positive isolates detected. Enterobacter cloacae
was the predominant organism (56%, n = 40), in a similar
proportion to the clinical isolates. Shower plumbing andally significant infections
ism Treatment 30-day Mortality
la pneumoniae Amikacin 4 days Survived
acter cloacae Amikacin 14 days Survived
Ciprofloxacin 14 days
acter cloacae Surgical wound debridement, with
1 dose amikacin at time of operation
Survived
acter cloacae Amikacin 5 days Survived*
acter cloacae Amikacin 8 days, ciprofloxacin 7 days Survived
la pneumoniae
acter cloacae Stat dose amikacin, ciprofloxacin
6 days
Survived
la pneumoniae Unknown Unknown
injury, not attributed to MBL infection.
Figure 2 Temporal relationship during the prolonged outbreak comparing A) clinical, B) environmental and C) infection control
interventions; section B includes overall number of swabs taken during each quarter. Infection control (IC) interventions were; I. Access of
deep drains for cleaning; II. Extensive cleaning of all sinks and drains; III. Introduction of regular environmental surveys; IV. Terminal cleaning of
the Burns Unit; PA = denotes patients with known MBL colonization prior to transfer into Burns Unit.
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lates (Table 4). Despite sampling, MBL isolates were not
identified in any area not directly related to patient contact
or water drainage, e.g. nurses’ workstation, staff room or of-
fice areas. Figure 3 describes the close spatial relationship
between sites where environmental MBL isolates were de-
tected, especially the shower facilities, compared to the pa-





Isolates (n = 71)
Enterobacter cloacae 19 40
Enterobacter aerogenes 1 0
Klebsiella oxytoca 2 8
Klebsiella pneumoniae 8 0
Leclercia adecarboxylata 0 7
Citrobacter freundii 0 6
Escherichia hermannii 0 3
Pantoea species 0 4
Raoultella planticola 0 2
Serratia marcescens 0 1time of MBL acquisition. Figure 2 describes the temporal re-
lationship between MBL positive patients admitted into the
BU, against environmental isolates detected over the same
time period. It also denotes the instances when additional
intensive hospital cleaning measures were implemented, in
an attempt to eradicate MBL colonization within the unit.
Infection control interventions
Single room isolation and standard contact precautions (with
donning gowns and gloves in an anteroom prior to entry)
were pre-existing prior to introduction of MBL organisms
into the BU. There was good hand hygiene compliance
amongst staff, and the hospital had an established antibiotic
stewardship and approval program. Interventions in response
to the outbreak have therefore focused on hospital cleaning
and engineering solutions, especially as MBL organisms were
primarily isolated in recurring environmental niches.
In response to a growing number of MBL organisms
being found from drain sites, liaison with engineering
services allowed access by cleaning staff into floor drain-
age and sink traps that were previously screwed down,
and these deep drains were terminally cleaned by hos-
pital plumbers. In September 2010, regular physical
cleaning of drains to remove biofilm and additional
cleaning with double-strength phenolic disinfectant
Table 4 Environmental bla-IMP-4 MBL isolates by site
type
By Site Type N = 71
Shower Plumbing (e.g. drains, taps, sinks) 38
Shower Equipment (e.g. trolley, chair, curtain) 22
Room Plumbing (e.g. handwashing sink, taps) 4
Room Equipment (e.g. bed rail, suction equipment) 6
Other 1
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based product Chlor-clean™ in April 2012. In September
2011, point-prevalence surveillance of the environment
was performed to access the situation, in consultation
with the burns department, infection control, environ-
mental and engineering services. After this survey revealed
ongoing contamination of the unit, a concerted effort for
terminal cleaning of the Unit was performed in October
2011, and implementation of monthly routine surveil-
lance, including sampling both before and after hospital
cleaning. Despite this, 12 (32%) of the 37 positive environ-
mental isolates since October 2011 were samples obtained
after cleaning.
Discussion
We describe the persistence of MBL-producing organ-
isms in a nosocomial setting, detected from both clinical
and environmental sources, which has continued for six
years. A small but significant proportion of patients ad-
mitted to BU were colonized and/or infected, 1.5%, andFigure 3 Map of BU plotting MBL environmental isolates, compared aBU-related isolates were greatly overrepresented, ac-
counting for 55% of overall hospital MBL isolates de-
tected during this time. Case patients were significantly
older, with greater extent of burns and hospital lengths
of stay. Those with clinical infections had generally favor-
able outcomes, with no attributable deaths. Most cases
reflected asymptomatic colonization rather than clinical
infection, in contrast to a previously described outbreak in
the Intensive Care Unit at another Australian hospital,
where 75% of patients carrying MBL-organisms had at-
tributable infections [5].
Between 2000 and 2006, the predominant carbapenem-
resistant Gram-negative organism isolated from BU envir-
onmental screening was multidrug-resistant Acinetobacter
baumannii, conferring resistance via a Class D OXA-23
enzyme. Its presence was curtailed with improved envir-
onmental sampling methods [13] together with an effect-
ive surface cleaning intervention, which included hiring
of dedicated cleaners for the BU. Consequently MDR
A. baumannii ceased to be detected from the environ-
ment after this time.
Environmentally-isolated CRE were first detected in our
BU in January 2007, however molecular IMP-4 MBL
confirmation in environmental isolates had not been
instituted at that time, and these unconfirmed carbapenem-
resistant isolates were excluded in this study. Since molecu-
lar confirmation began in early 2008, MBL organisms have
been recurrently isolated, predominately within the shower
facilities that are shared amongst the patients. Our findings
of multi-resistant Gram-negative organisms persisting ingainst rooms dwelled by MBL positive patients.
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periences described both locally [7], and overseas [8,9,14,15],
of outbreaks related to plumbing and water-borne sources
[16]. These studies, as well as genomic data from selected
clinical and environmental isolates from our BU [11],
suggest a close association between environmental
sources, colonization and secondary infection. How-
ever, unlike outbreaks that have largely centered around
handwashing sinks, the vast majority of positive environ-
mental isolates originated from drains and sluices within
the BU shower facilities, though not the shower heads
themselves. We postulate that severe burns patients’ large
surface areas of denuded and exposed skin, and require-
ment for regular bathing, puts them at greater risk of
colonization by environmental Gram-negative organisms
that may have a water-related reservoir [17], particularly if
associated with biofilms [8].
While some studies have found implementation of in-
fection control bundled interventions, such as universal
standard precautions with antibiotic stewardship, have
eradicated local outbreaks of multi-resistant Gram-
negative organisms [6,18], others have experienced out-
breaks despite this [19]. Existence of such measures in
our BU well before outbreak onset did not prevent its
establishment or dissemination, although it may have
limited its potential magnitude. Although terminal clean-
ing within our BU terminated an MDR-Acinetobacter bau-
mannii outbreak six years previously, repeated attempts at
cleaning interventions targeting structural plumbing com-
ponents have not resulted in elimination of MBLs from
the environment. This may be related to the persistence of
biofilms despite terminal cleaning [20]. CRE outbreaks in
other settings have involved physical removal of plumbing,
together with other infection control measures, with sub-
sequent success at terminating the outbreak [9,15].
We recognize that the association of MBLs detected in
clinical and environmental isolates cannot prove causal-
ity. In fact this has, until recently, hampered discussion
of the role of the environment in transmission of En-
terobacteriaceae between patients and the importance of
hospital cleaning in control. Even though the MBL iso-
lates in both clinical and environmental samples were
shown to be genetically identical [11], this does not con-
firm the reservoir as the definitive source of transmis-
sion to newly admitted patients. Nonetheless, apart from
the BU staff, the only environment shared between pa-
tients, were the shower and bathroom facilities. There
was continuing environmental detection and despite
concerted terminal cleaning, persistence of MBLs in
these, independent of the concomitant presence in the
BU of MBL positive patients. We believe the consistency
of our findings in a unique patient niche, in association
with similar findings emerging in the literature to echo
our experience [9,15] would suggest that environmentalreservoirs for multi-resistant Enterobacteriaceae are a
potential source for ongoing cross-contamination.
Novel approaches to environmental disinfection, such
as hydrogen peroxide vapor decontamination [21,22] are
being trialed, however this approach may be more effica-
cious against surface environmental organisms such as
MRSA and VRE, and efficacy against Enterobacteriaceae,
especially those with an established water source, have
not been demonstrated to date.
One limitation to this retrospective study was the ir-
regular nature of surveillance from both clinical and en-
vironmental sources, which potentially missed a proportion
of asymptomatic colonization, and potential environmental
reservoirs, due to the selective nature of environmental
sampling. This study highlights the importance for active
surveillance during an outbreak and in high-risk settings
such as the Burns Unit, as recommended by the Centre of
Disease Control regarding the control of CREs [23]. A re-
cent carbapenem-resistant Klebsiella pneumoniae outbreak
at a National Institutes of Health hospital involved whole-
genome sequencing to track the origin of the outbreak and
delineate its epidemiology [10]. Real-time sequencing may
prove a useful tool in the future as cost-effectiveness and
technological improvements may lead to mainstream clin-
ical use.
Laboratory detection methods carried out at the be-
ginning of the outbreak may have under-detected the
burden of MBLs in both clinical and environmental iso-
lates, as automated systems may miss carbapenemase-
producing organisms [24,25], and CLSI breakpoints were
lowered in 2010 to facilitate greater detection of CREs
[26]. Despite this, we observed that improving the sensi-
tivity of laboratory CRE detection, particularly for envir-
onmental CRE organisms, required the addition of a
lower MIC (0.5 mg/L meropenem) agar dilution plate.
Developing rapid diagnostic tests to detect CREs is diffi-
cult, especially for environmental screening purposes,
due to their multiple and complex resistance mecha-
nisms [27], and also in screening a multitude of organ-
isms, some of which may only exhibit low-level
resistance. Such a test would allow prompt identifica-
tion of carrier patients, incur appropriate infection
control measures, and delineate the extent outbreak
before its spread. We have recently evaluated the Car-
baNP test as a simple, cost-effective test for CRE testing
[28] and hope to implement this in routine environmental
screening for bla-IMP-4 organisms.
Further studies are required to explore the long-term
outcome of patients colonized with MBL organisms, and
whether chronic carriage persists after hospital dis-
charge. The persistence of CRE in the nosocomial set-
ting despite traditional measures signal a need to pursue
newer approaches, including novel cleaning methods,
assessing the need for removing physical structures, such
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and the role active surveillance plays in monitoring and
curtailing outbreaks.
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